Baicalin
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Baicalin
Description :
Baicalin, as a flavonoid glycoside, is an allosteric carnitine palmityl transferase 1 (CPT1) activator. Baicalin reduces the expression of NF-κB[1][2][3].Product Name Alternative :
Baicalein 7-O-β-D-glucuronideUNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Autophagy; HIV; NF-κBType :
Natural ProductsRelated Pathways :
Anti-infection; Autophagy; NF-κBApplications :
COVID-19-anti-virusField of Research :
Inflammation/Immunology; CancerAssay Protocol :
https://www.medchemexpress.com/Baicalin.htmlConcentration :
10mMPurity :
99.17Solubility :
DMSO : ≥ 100 mg/mL|H2O : < 0.1 mg/mL (ultrasonic)Smiles :
O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=C(O)C(O)=C3C(C=C(C4=CC=CC=C4)OC3=C2)=OMolecular Formula :
C21H18O11Molecular Weight :
446.36Precautions :
H302, H315, H319, H335References & Citations :
[1]Lin M, et al. The protective effect of Baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis. BMC Complement Altern Med. 2014 Jan 13;14:19.|[2]Ju XN, et al. Baicalin protects against thrombin induced cell injury in SH-SY5Y cells. Int J Clin Exp Pathol. 2015 Nov 1;8 (11) :14021-7.|[3]Dai J, et al. Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis. Proc Natl Acad Sci U S A. 2018;115 (26) :E5896-E5905.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Natural ProductsClinical Information :
LaunchedIsoform :
NF-κBCAS Number :
[21967-41-9]

